Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Fish and Richardson
UBS
Argus Health
Cantor Fitzgerald
Cipla
US Department of Justice
Daiichi Sankyo
Queensland Health

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018933

« Back to Dashboard

NDA 018933 describes M.V.I.-12 LYOPHILIZED, which is a drug marketed by Teligent Pharma Inc and is included in one NDA. Additional details are available on the M.V.I.-12 LYOPHILIZED profile page.

The generic ingredient in M.V.I.-12 LYOPHILIZED is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine; riboflavin 5'-phosphate sodium; thiamine; vitamin a; vitamin e. There are six drug master file entries for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine; riboflavin 5'-phosphate sodium; thiamine; vitamin a; vitamin e profile page.
Summary for 018933
You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE','VITAMIN A','VITAMIN E') AND hsdb_drugname IS NOT NULL' at line 1
Tradename:M.V.I.-12 LYOPHILIZED
Applicant:Teligent Pharma Inc
Ingredient:ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine; riboflavin 5'-phosphate sodium; thiamine; vitamin a; vitamin e
Patents:0